Viatris Inc Stock Research

Market Summary

USD9.500.00

Market Closed

0.00%

VTRS Alerts

Big fall in Revenue (Y/Y)
Big jump in Earnings (Y/Y)

VTRS Stock Price

VTRS RSI Chart

VTRS Valuation

Market Cap

11.5B

Price/Earnings (Trailing)

5.54

Price/Sales (Trailing)

0.71

EV/EBITDA

1.59

Price/Free Cashflow

4.52

VTRS Price/Sales (Trailing)

VTRS Profitability

EBT Margin

17.35%

Return on Equity

9.86%

Return on Assets

4.16%

Free Cashflow Yield

22.11%

VTRS Fundamentals

VTRS Revenue

Revenue (TTM)

16.2B

Revenue Y/Y

-10.72%

Revenue Q/Q

-4.92%

VTRS Earnings

Earnings (TTM)

2.1B

Earnings Y/Y

483.32%

Earnings Q/Q

185.41%

Price Action

52 Week Range

8.3312.40

(Low)(High)

Last 7 days

-10.0%

Last 30 days

-20.7%

Last 90 days

-14.7%

Trailing 12 Months

-1.4%

VTRS Financial Health

Current Ratio

1.58

VTRS Investor Care

Dividend Yield

5.05%

Dividend/Share (TTM)

0.48

Shares Dilution (1Y)

0.26%

Diluted EPS (TTM)

1.71

Peers (Alternatives to Viatris)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
AAPL	2.5T	387.5B	-0.56%	-0.91%	25.94	6.37	2.44%	-5.35%
MSFT	2.1T	204.1B	-1.92%	-6.89%	30.5	10.08	10.38%	-5.25%
GOOG	1.3T	282.8B	1.63%	-25.54%	21.65	4.59	9.78%	-21.12%
AMZN	1.0T	514.0B	-3.36%	-34.72%	-376.42	1.99	9.40%	-108.16%
MID-CAP
NYMT	3.6B	258.4M	203.99%	176.76%	-11.9	13.75	24.91%	-254.56%
JBLU	2.3B	9.2B	-18.97%	-49.38%	-6.41	0.25	51.67%	-98.90%
SMALL-CAP
PLAY	1.7B	1.7B	-22.36%	-14.62%	13.72	0.97	61.79%	371.82%
TLRY	1.6B	602.5M	-17.77%	-52.80%	-2.74	2.63	18.18%	-18.59%
BYND	1.1B	418.9M	5.51%	-56.16%	-2.93	2.57	-9.85%	-101.06%
CGC	991.7M	478.9M	-11.35%	-65.42%	-0.32	2.07	-31.50%	-634.70%
MFA	954.9M	482.4M	-16.25%	-37.64%	-4.12	1.98	33.15%	-170.42%
NKLA	897.6M	50.8M	-34.66%	-77.56%	-1.14	17.66	1229.98%	-13.59%
GPRO	788.4M	1.1B	-10.56%	-33.33%	27.33	0.72	-5.82%	-92.23%
INO	281.8M	10.3M	-24.84%	-63.38%	-1.01	27.46	478.23%	7.85%

Financials for Viatris

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Revenue	-2.8%	16,218	16,682	17,135	17,592	17,814
Gross Profit	-4.0%	6,497	6,769	6,595	6,219	5,576
Operating Expenses	-3.0%	4,882	5,031	5,059	5,280	5,610
S&GA Expenses	4.6%	4,179	3,997	4,034	4,258	4,529
R&D Expenses	3.1%	747	724	709	751	-
EBITDA	38.6%	6,433	4,642	4,730	4,738	-
EBITDA Margin	42.6%	0.40*	0.28*	0.28*	0.27*	-
Earnings Before Taxes	146.7%	2,813	1,140	913	304	-664
EBT Margin	153.7%	0.17*	0.07*	0.05*	0.02*	-
Interest Expenses	-0.2%	592	594	592	613	636
Net Income	158.7%	2,079	804	761	168	-1,269
Net Income Margin	166.1%	0.13*	0.05*	0.04*	0.01*	-
Free Cahsflow	-11.7%	2,547	2,883	3,083	2,834	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Assets	2.8%	50,022	48,663	51,125	53,467	54,843
Current Assets	1.4%	10,635	10,488	11,177	11,744	10,903
Cash Equivalents	94.8%	1,260	647	665	752	701
Inventory	4.1%	3,520	3,380	3,613	3,797	3,978
Net PPE	-0.5%	3,025	3,039	3,084	3,150	3,189
Goodwill	3.7%	10,426	10,055	10,523	10,979	12,114
Liabilities	-1.8%	28,950	29,480	31,320	33,019	34,350
Current Liabilities	3.4%	6,746	6,521	7,681	9,643	9,884
. Short Term Borrowings	-100.0%	-	500	1,020	655	1,493
LT Debt, Current	64.8%	1,259	764	768	2,606	1,878
LT Debt, Non Current	-3.8%	18,015	18,725	19,206	18,763	19,717
Shareholder's Equity	9.9%	21,072	19,182	19,805	20,448	20,493
Retained Earnings	20.0%	5,176	4,313	4,107	3,942	3,689
Additional Paid-In Capital	0.2%	18,646	18,617	18,586	18,555	18,536
Shares Outstanding	0.0%	1,213	1,212	1,211	-	-

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Cashflow From Operations	-11.4%	2,953	3,333	3,550	3,307	3,017
Share Based Compensation	6.5%	116	109	105	107	111
Cashflow From Investing	414.7%	1,521	-483	-486	-421	-117
Cashflow From Financing	-33.9%	-3,877	-2,896	-3,015	-2,921	-3,012

Risks for VTRS

What is the probability of a big loss on VTRS?

100%

Probability that Viatris stock will be more than 20% underwater in next one year

72.3%

Probability that Viatris stock will be more than 30% underwater in next one year.

30%

Probability that Viatris stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does VTRS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Viatris was unfortunately bought at previous high price.

Drawdowns

Returns for VTRS

Cumulative Returns on VTRS

-10.4%

10-Year Cumulative Returns

-19.5%

7-Year Cumulative Returns

-24.7%

5-Year Cumulative Returns

-12.4%

3-Year Cumulative Returns

What are the long-term rolling returns for VTRS?

FIve years rolling returns for Viatris.

Annualized Returns

Which funds bought or sold VTRS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-03-15	B. Riley Wealth Advisors, Inc.	added	18.18	165,615	472,615	0.01%
2023-03-10	VICTORY CAPITAL MANAGEMENT INC	added	31.97	12,651,000	30,126,000	0.03%
2023-03-10	MATHER GROUP, LLC.	new	-	132,814	132,814	-%
2023-03-06	Rockefeller Capital Management L.P.	reduced	-12.2	42,000	326,000	-%
2023-03-06	BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL	added	13.3	342,321	1,053,320	0.40%
2023-03-03	TIAA, FSB	added	17.81	73,890	209,890	-%
2023-03-02	LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA	new	-	51,943	51,943	-%
2023-03-02	OLIVER LAGORE VANVALIN INVESTMENT GROUP	reduced	-80.7	124	124	-%
2023-03-01	Lakewood Asset Management LLC	new	-	5,000	5,000	-%
2023-02-28	Voya Investment Management LLC	added	4.58	1,309,940	4,886,940	0.01%

Latest Funds Activity

Are funds buying VTRS calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own VTRS

No. of Funds

Viatris News

Schedule 13G FIlings of Viatris

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2023	vanguard group inc	12.31%	149,318,666	SC 13G/A
Feb 07, 2023	state street corp	5.10%	61,903,672	SC 13G
Jan 31, 2023	blackrock inc.	7.7%	93,214,306	SC 13G/A
Feb 04, 2022	wellington management group llp	4.57%	55,233,099	SC 13G/A
Feb 03, 2022	blackrock inc.	7.2%	86,554,658	SC 13G/A
Feb 04, 2021	wellington management group llp	5.74%	69,811,210	SC 13G
Feb 02, 2021	blackrock inc.	7.3%	89,526,414	SC 13G
Jan 08, 2021	vanguard group inc	10.62%	129,072,141	SC 13G

VTRS Fair Value

Viatris fair value in different scenarios

The table shows the Fair Value estimates for Viatris for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	- -	- -	- -	- -	- -
Current Inflation	4.11 -56.74%	5.02 -47.16%	6.82 -28.21%	9.68 1.89%	13.11 38.00%
Very High Inflation	- -	- -	- -	- -	- -

Historical Viatris Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Viatris

View All Filings

Date Filed	Form Type	Document
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading
Mar 06, 2023	4	Insider Trading

Latest Insider Trading transactions for VTRS

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-03-06	Ni Xiangyang (Sean)	sold	-34,890	11.0835	-3,148	president, greater china
2023-03-04	Cuneo Andrew	acquired	-	-	6,518	see remarks
2023-03-04	Campbell Paul	acquired	-	-	18,515	see remarks
2023-03-04	PARRISH MARK W	acquired	-	-	20,313	-
2023-03-04	Lyons Dillon JoEllen	acquired	-	-	20,313	-
2023-03-04	van der Meer Mohr Pauline	sold (taxes)	-6,800	11.13	-611	-
2023-03-04	van der Meer Mohr Pauline	acquired	-	-	20,313	-
2023-03-04	Mauro Anthony	acquired	-	-	37,917	see remarks
2023-03-04	GOETTLER MICHAEL	acquired	-	-	107,827	chief executive officer
2023-03-04	GOETTLER MICHAEL	sold (taxes)	-525,425	11.13	-47,208	chief executive officer

About Viatris

Michael Goettler

www.viatris.com

37000

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

VTRS Income Statement

2022-12-31

Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues:
Net sales	$ 16,218.1	$ 17,813.6	$ 11,819.9
Total revenues	16,262.7	17,886.3	11,946.0
Cost of sales	9,765.7	12,310.8	8,149.3
Gross profit	6,497.0	5,575.5	3,796.7
Operating expenses:
Research and Development Expense	662.2	681.0	512.6
Acquired IPR&D	36.4	70.1	42.5
Selling, general and administrative	4,179.1	4,529.2	3,344.6
Litigation settlements and other contingencies, net	4.4	329.2	107.8
Total operating expenses	4,882.1	5,609.5	4,007.5
Earnings (loss) from operations	1,614.9	(34.0)	(210.8)
Interest expense	592.4	636.2	497.8
Other (income) expense, net	(1,790.7)	(5.8)	12.6
Earnings (loss) before income taxes	2,813.2	(664.4)	(721.2)
Income tax provision (benefit)	734.6	604.7	(51.3)
Net earnings (loss)	$ 2,078.6	$ (1,269.1)	$ (669.9)
Earnings (loss) per share attributable to Viatris Inc. shareholders
Basic (in USD per share)	$ 1.71	$ (1.05)	$ (1.11)
Diluted (in USD per share)	$ 1.71	$ (1.05)	$ (1.11)
Weighted average shares outstanding:
Basic (in shares)	1,212.1	1,208.8	601.2
Diluted (in shares)	1,217.4	1,208.8	601.2
Net sales
Revenues:
Net sales	$ 16,218.1	$ 17,813.6	$ 11,819.9
Other revenues
Revenues:
Other revenues	$ 44.6	$ 72.7	$ 126.1

VTRS Balance Sheet

2022-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,259,900	$ 701,200
Accounts receivable, net	3,814,500	4,266,400
Inventories	3,519,500	3,977,700
Prepaid expenses and other current assets	1,811,200	1,957,600
Assets held for sale	230,300	0
Total current assets	10,635,400	10,902,900
Property, plant and equipment, net	3,024,500	3,188,600
Intangible assets, net	22,607,100	26,134,200
Goodwill	10,425,800	12,113,700
Deferred income tax benefit	925,900	1,332,700
Other assets	2,403,500	1,170,700
Total assets	50,022,200	54,842,800
Current liabilities:
Accounts payable	1,766,600	1,657,400
Short-term borrowings	0	1,493,000
Income taxes payable	279,600	236,900
Current portion of long-term debt and other long-term obligations	1,259,100	1,877,500
Other current liabilities	3,440,900	4,619,600
Total current liabilities	6,746,200	9,884,400
Long-term debt	18,015,200	19,717,100
Deferred income tax liability	2,432,000	2,815,000
Other long-term obligations	1,756,500	1,933,600
Total liabilities	28,949,900	34,350,100
Viatris Inc. shareholders’ equity
Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued and outstanding: 1,213,793,231 and 1,209,507,463, respectively	12,100	12,100
Additional paid-in capital	18,645,800	18,536,100
Retained earnings	5,175,600	3,688,800
Accumulated other comprehensive loss	(2,761,200)	(1,744,300)
Total equity	21,072,300	20,492,700
Total liabilities and equity	$ 50,022,200	$ 54,842,800